Concord Medical Services Holdings Limited (CCM) P/E Ratio History
Historical price-to-earnings valuation from 2013 to 2014
Loading P/E history...
Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of March 2, 2026, Concord Medical Services Holdings Limited (CCM) trades at a price-to-earnings ratio of -0.0x, with a stock price of $3.64 and trailing twelve-month earnings per share of $-1120.21.
The current P/E is 101% below its 5-year average of 1.2x. Over the past five years, CCM's P/E has ranged from a low of 0.8x to a high of 1.5x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 23.7x, CCM trades at a 100% discount to its sector peers. The sector includes 224 companies with P/E ratios ranging from 0.0x to 184.4x.
Relative to the broader market, CCM trades at a notable discount to the S&P 500 median P/E of 26.2x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our CCM DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
Peer Comparison
P/E metrics vs. Specialty chronic care clinics peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
FMSFresenius Medical Care AG & Co. KGaA | $14B | 11.8Lowest | 2.32Best | +83%Best |
DVADaVita Inc. | $10B | 17.2 | 2.38 | -15% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
Historical P/E Data
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2014 Q4 | Wed Dec 31 2014 00:00:00 GM | $64.10 | $78.00 | 0.8x | -29% |
| FY2013 Q4 | $48.14 | $32.40 | 1.5x | +29% |
Average P/E for displayed period: 1.2x
See CCM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CCM Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare CCM vs AGIO
See how CCM stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is CCM stock overvalued or undervalued?
CCM current P/E: -0.0x. 5-year average P/E: 1.2x. Percentile: N/A.
How does CCM's valuation compare to peers?
Concord Medical Services Holdings Limited P/E of -0.0x compares to sector median of 23.7x. Sector comparison provides relative valuation context.
What is CCM's PEG ratio?
CCM PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2013-2014.